{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:25:41Z","timestamp":1781166341822,"version":"3.54.1"},"reference-count":116,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>B-cell lymphomas are a group of heterogeneous neoplasms resulting from the clonal expansion of mature B cells arrested at various stages of differentiation. Specifically, two lymphoma subtypes arise from germinal centers (GCs), namely follicular lymphoma (FL) and GC B-cell diffuse large B-cell lymphoma (GCB-DLBCL). In addition to recent advances in describing the genetic landscape of FL and GCB-DLBCL, tumor microenvironment (TME) has progressively emerged as a central determinant of early lymphomagenesis, subclonal evolution, and late progression\/transformation. The lymphoma-supportive niche integrates a dynamic and coordinated network of immune and stromal cells defining microarchitecture and mechanical constraints and regulating tumor cell migration, survival, proliferation, and immune escape. Several questions are still unsolved regarding the interplay between lymphoma B cells and their TME, including the mechanisms supporting these bidirectional interactions, the impact of the kinetic and spatial heterogeneity of the tumor niche on B-cell heterogeneity, and how individual genetic alterations can trigger both B-cell intrinsic and B-cell extrinsic signals driving the reprogramming of non-malignant cells. Finally, it is not clear whether these interactions might promote resistance to treatment or, conversely, offer valuable therapeutic opportunities. A major challenge in addressing these questions is the lack of relevant models integrating tumor cells with specific genetic hits, non-malignant cells with adequate functional properties and organization, extracellular matrix, and biomechanical forces. We propose here an overview of the 3D <jats:italic>in vitro<\/jats:italic> models, xenograft approaches, and genetically-engineered mouse models recently developed to study GC B-cell lymphomas with a specific focus on the pros and cons of each strategy in understanding B-cell lymphomagenesis and evaluating new therapeutic strategies.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1288110","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T16:59:06Z","timestamp":1698944346000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Modeling the crosstalk between malignant B cells and their microenvironment in B-cell lymphomas: challenges and opportunities"],"prefix":"10.3389","volume":"14","author":[{"given":"Baptiste","family":"Brauge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Dessauge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Creusat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Tarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12983","article-title":"B cell\/stromal cell crosstalk in health, disease, and treatment: Follicular lymphoma as a paradigm","volume":"302","author":"Lamaison","year":"2021","journal-title":"Immunol Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000914","article-title":"Development and immunological function of lymph node stromal cells","volume":"206","author":"Pikor","year":"2021","journal-title":"J Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nri3814","article-title":"Germinal centres and B cell lymphomagenesis","volume":"15","author":"Basso","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/bs.ai.2021.05.002","article-title":"Follicular lymphoma dynamics","volume":"150","author":"Milpied","year":"2021","journal-title":"Adv Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-cell lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000440","article-title":"Microenvironment signaling driving lymphomagenesis","volume":"25","author":"Verdi\u00e8re","year":"2018","journal-title":"Curr Opin Hematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.127","article-title":"From genetics to the clinic: a translational perspective on follicular lymphoma","volume":"18","author":"Huet","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.784691","article-title":"Bone marrow lymphoid niche adaptation to mature B cell neoplasms","volume":"12","author":"Dumontet","year":"2021","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3774","article-title":"The tumour microenvironment in B cell lymphomas","volume":"14","author":"Scott","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0839","article-title":"Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures","volume":"11","author":"Kotlov","year":"2021","journal-title":"Cancer Discov"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI166070","article-title":"Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma","volume":"133","author":"Apollonio","year":"2023","journal-title":"J Clin Invest"},{"key":"B14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/(sici)1099-1069(199711)15:4<197::aid-hon614>3.0.co;2-v","article-title":"T-cell derived cytokines co-stimulate proliferation of CD40-activated germinal centre as well as follicular lymphoma cells","volume":"15","author":"Schmitter","year":"1997","journal-title":"Hematol Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.223","article-title":"Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis","volume":"24","author":"Pangault","year":"2010","journal-title":"Leukemia"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.301","article-title":"Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of Malignant B cells","volume":"26","author":"Am\u00e9-Thomas","year":"2012","journal-title":"Leukemia"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-023-01495-3","article-title":"Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas","volume":"22","author":"Shah","year":"2023","journal-title":"Nat Mater"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00280","article-title":"Stromal cell contribution to human follicular lymphoma pathogenesis","volume":"3","author":"Mourcin","year":"2012","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1182\/blood-2006-05-020800","article-title":"Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis","volume":"109","author":"Am\u00e9-Thomas","year":"2007","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-370908","article-title":"Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes","volume":"119","author":"Guilloton","year":"2012","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-275925","article-title":"Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a","volume":"116","author":"Lwin","year":"2010","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.266","article-title":"Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin\u2019s B lymphoma cells from apoptosis","volume":"23","author":"Lwin","year":"2009","journal-title":"Leukemia"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-737239","article-title":"IL-4\/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma","volume":"129","author":"Pandey","year":"2017","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.605231","article-title":"Developing a 3D B cell lymphoma culture system to model antibody therapy","volume":"11","author":"Foxall","year":"2020","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.immuni.2021.05.019","article-title":"Follicular lymphoma triggers phenotypic and functional remodeling of the human lymphoid stromal cell landscape","volume":"54","author":"Mourcin","year":"2021","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.09.018","article-title":"Cell growth in aggregates determines gene expression, proliferation, survival, chemoresistance, and sensitivity to immune effectors in follicular lymphoma","volume":"184","author":"Gravelle","year":"2014","journal-title":"Am J Pathol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1038\/bcj.2013.32","article-title":"Anti-tumor activity of obinutuzumab and rituximab in a follicular lymphoma 3D model","volume":"3","author":"Decaup","year":"2013","journal-title":"Blood Cancer J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01943","article-title":"A tridimensional model for NK cell-mediated ADCC of follicular lymphoma","volume":"10","author":"Decaup","year":"2019","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1554175","article-title":"Boosting \u03b3\u03b4 T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma","volume":"8","author":"Rossi","year":"2019","journal-title":"Oncoimmunology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071490","article-title":"3D model characterization by 2D and 3D imaging in t(14;18)-positive B-NHL: perspectives for in vitro drug screens in follicular lymphoma","volume":"13","author":"Gava","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.actbio.2018.05.034","article-title":"Design of spherically structured 3D in vitro tumor models -Advances and prospects","volume":"75","author":"Ferreira","year":"2018","journal-title":"Acta Biomater"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S363994","article-title":"Development and characterization of 3D hybrid spheroids for the investigation of the crosstalk between B-cell non-Hodgkin lymphomas and mesenchymal stromal cells","volume":"15","author":"Du\u015b-Szachniewicz","year":"2022","journal-title":"Onco Targets Ther"},{"key":"B33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jconrel.2018.12.010","article-title":"Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release","volume":"295","author":"Sabhachandani","year":"2019","journal-title":"J Control Release"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1039\/c6lc01204c","article-title":"3D microvascular model recapitulates the diffuse large B-cell lymphoma tumor microenvironment in vitro","volume":"17","author":"Mannino","year":"2017","journal-title":"Lab Chip"},{"key":"B35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.biomaterials.2015.06.002","article-title":"Ex vivo engineered immune organoids for controlled germinal center reactions","volume":"63","author":"Purwada","year":"2015","journal-title":"Biomaterials"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nmat4157","article-title":"Light-triggered in vivo activation of adhesive peptides regulates cell adhesion, inflammation and vascularization of biomaterials","volume":"14","author":"Lee","year":"2015","journal-title":"Nat Mater"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2015.09.007","article-title":"Integrin-specific hydrogels as adaptable tumor organoids for Malignant B and T cells","volume":"73","author":"Tian","year":"2015","journal-title":"Biomaterials"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nri3846","article-title":"Lymph node fibroblastic reticular cells in health and disease","volume":"15","author":"Fletcher","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.36031","article-title":"Award Winner in the Young Investigator Category, 2017 Society for Biomaterials Annual Meeting and Exposition, Minneapolis, MN, April 05-08, 2017: Lymph node stiffness-mimicking hydrogels regulate human B-cell lymphoma growth and cell surface receptor expression in a molecular subtype-specific manner","volume":"105","author":"Apoorva","year":"2017","journal-title":"J BioMed Mater Res A"},{"key":"B40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.celrep.2018.03.069","article-title":"How biophysical forces regulate human B cell lymphomas","volume":"23","author":"Apoorva","year":"2018","journal-title":"Cell Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003949","article-title":"A novel 3D culture model recapitulates primary FL B-cell features and promotes their survival","volume":"5","author":"Lamaison","year":"2021","journal-title":"Blood Adv"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-321265","article-title":"Cooperative function of CCR7 and lymphotoxin in the formation of a lymphoma-permissive niche within murine secondary lymphoid organs","volume":"118","author":"Rehm","year":"2011","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109878","article-title":"Lymphocyte access to lymphoma is impaired by high endothelial venule regression","volume":"37","author":"Menzel","year":"2021","journal-title":"Cell Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1158\/1078-0432.CCR-16-0040","article-title":"CTLA-4 limits anti-CD20-mediated tumor regression","volume":"23","author":"Ren","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-223958","article-title":"Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion","volume":"114","author":"Houot","year":"2009","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-170274","article-title":"T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy","volume":"113","author":"Houot","year":"2009","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd4344","article-title":"A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity","volume":"6","author":"Boulch","year":"2021","journal-title":"Sci Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-175125","article-title":"Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20","volume":"113","author":"Dayd\u00e9","year":"2009","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106658","article-title":"Functional heterogeneity of cytotoxic T cells and tumor resistance to cytotoxic hits limit anti-tumor activity in vivo","volume":"40","author":"Khazen","year":"2021","journal-title":"EMBO J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"5419","DOI":"10.1038\/s41598-023-32547-y","article-title":"HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models","volume":"13","author":"Ke","year":"2023","journal-title":"Sci Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01564","article-title":"Mouse models of c-myc deregulation driven by IgH locus enhancers as models of B-cell lymphomagenesis","volume":"11","author":"Ferrad","year":"2020","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-1189","article-title":"BCL6 antagonizes NOTCH2 to maintain survival of human follicular lymphoma cells","volume":"7","author":"Valls","year":"2017","journal-title":"Cancer Discov"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-804344","article-title":"Mechanisms of resistance to EZH2 inhibitors in diffuse large B-cell lymphomas","volume":"131","author":"Bisserier","year":"2018","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.619236","article-title":"Advances in human immune system mouse models for studying human hematopoiesis and cancer immunotherapy","volume":"11","author":"Mian","year":"2020","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/ni1527","article-title":"Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells","volume":"8","author":"Takenaka","year":"2007","journal-title":"Nat Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","article-title":"Humanized mouse models for immuno-oncology research","volume":"20","author":"Chuprin","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-018-0071-6","article-title":"A human immune system mouse model with robust lymph node development","volume":"15","author":"Li","year":"2018","journal-title":"Nat Methods"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/srep13054","article-title":"Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cells","volume":"5","author":"Sugimoto","year":"2015","journal-title":"Sci Rep"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2703","article-title":"B-cell lymphoma patient-derived xenograft models enable drug discovery and are a platform for personalized therapy","volume":"23","author":"Zhang","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-672352","article-title":"Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1393","article-title":"Mechanisms of lymphoma clearance induced by high-dose alkylating agents","volume":"9","author":"Lossos","year":"2019","journal-title":"Cancer Discov"},{"key":"B65","unstructured":"Functional precision oncology for follicular lymphoma with patient-derived xenograft in avian embryos\n            ZalaM\n            LipinskiB\n            CostechareyreC\n            JarrossonL\n            TeinturierR\n            JuliaE\n          10.1101\/2023.06.22.546045bioRxiv2023"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-684183","article-title":"B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice","volume":"127","author":"Knittel","year":"2016","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj7412","article-title":"BTG1 mutation yields supercompetitive B cells primed for Malignant transformation","volume":"379","author":"Mlynarczyk","year":"2023","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.683597","article-title":"Human B lymphomas reveal their secrets through genetic mouse models","volume":"12","author":"Mossadegh-Keller","year":"2021","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17990","article-title":"The molecular ontogeny of follicular lymphoma: gene mutations succeeding the BCL2 translocation define common precursor cells","volume":"196","author":"Haebe","year":"2022","journal-title":"Br J Haematol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.8190","article-title":"t (14,18) Translocation: A predictive blood biomarker for follicular lymphoma","volume":"32","author":"Roulland","year":"2014","journal-title":"J Clin Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2469","article-title":"VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia","volume":"103","author":"Egle","year":"2004","journal-title":"Blood"},{"key":"B72","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0092-8674(89)90174-8","article-title":"bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation","volume":"57","author":"McDonnell","year":"1989","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ccell.2018.08.006","article-title":"MEF2B instructs germinal center development and acts as an oncogene in B cell lymphomagenesis","volume":"34","author":"Brescia","year":"2018","journal-title":"Cancer Cell"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.19.8661","article-title":"Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease","volume":"88","author":"Strasser","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"B75","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-387663-8.00002-8","article-title":"The IgH locus 3\u2019 regulatory region: pulling the strings from behind","volume":"110","author":"Pinaud","year":"2011","journal-title":"Adv Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.115","article-title":"The immunoglobulin heavy chain gene 3\u2019 enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells","volume":"25","author":"Xiang","year":"2011","journal-title":"Leukemia"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215337","article-title":"Distinct B-cell specific transcriptional contexts of the BCL2 oncogene impact pre-malignant development in mouse models","volume":"14","author":"Zawil","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1172\/JCI72415","article-title":"Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression","volume":"124","author":"Sungalee","year":"2014","journal-title":"J Clin Invest"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-0111","article-title":"Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors","volume":"13","author":"Schroers-Martin","year":"2023","journal-title":"Cancer Discov"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3943","article-title":"The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development","volume":"21","author":"Ortega-Molina","year":"2015","journal-title":"Nat Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-1417","article-title":"The CREBBP acetyltransferase is a haploinsufficient tumor suppressor in B-cell lymphoma","volume":"7","author":"Zhang","year":"2017","journal-title":"Cancer Discov"},{"key":"B83","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1158\/2159-8290.CD-16-0975","article-title":"CREBBP inactivation promotes the development of HDAC3-dependent lymphomas","volume":"7","author":"Jiang","year":"2017","journal-title":"Cancer Discov"},{"key":"B84","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.immuni.2019.08.006","article-title":"Unique and shared epigenetic programs of the CREBBP and EP300 acetyltransferases in germinal center B cells reveal targetable dependencies in lymphoma","volume":"51","author":"Meyer","year":"2019","journal-title":"Immunity"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-733469","article-title":"Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice","volume":"129","author":"Garc\u00eda-Ram\u00edrez","year":"2017","journal-title":"Blood"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2218330120","article-title":"KMT2D acetylation by CREBBP reveals a cooperative functional interaction at enhancers in normal and Malignant germinal center B cells","volume":"120","author":"Vlasevska","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1619555114","article-title":"Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth","volume":"114","author":"Hashwah","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B89","doi-asserted-by":"publisher","first-page":"528351","DOI":"10.1101\/2023.02.13.528351","article-title":"Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B cell fate decisions and yields T cell-depleted lymphomas","volume":"2023","author":"Li","year":"2023","journal-title":"BioRxiv"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00437-8","article-title":"CREBBP\/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2\/CSF1 axis","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B91","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41467-017-01029-x","article-title":"EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop","volume":"8","author":"B\u00e9guelin","year":"2017","journal-title":"Nat Commun"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1172\/JCI70626","article-title":"Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis","volume":"123","author":"Caganova","year":"2013","journal-title":"J Clin Invest"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.04.011","article-title":"EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation","volume":"23","author":"B\u00e9guelin","year":"2013","journal-title":"Cancer Cell"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4092","article-title":"An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation","volume":"22","author":"Souroullas","year":"2016","journal-title":"Nat Med"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1090","article-title":"Molecular and genetic characterization of MHC deficiency identifies EZH2 as therapeutic target for enhancing immune recognition","volume":"9","author":"Ennishi","year":"2019","journal-title":"Cancer Discov"},{"key":"B96","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.immuni.2020.11.002","article-title":"Genome-wide screens identify lineage- and tumor-specific genes modulating MHC-I- and MHC-II-restricted immunosurveillance of human lymphomas","volume":"54","author":"Dersh","year":"2021","journal-title":"Immunity"},{"key":"B97","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.molimm.2020.01.006","article-title":"EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomas","volume":"119","author":"Otsuka","year":"2020","journal-title":"Mol Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ccell.2020.04.004","article-title":"Mutant EZH2 induces a pre-malignant lymphoma niche by reprogramming the immune response","volume":"37","author":"B\u00e9guelin","year":"2020","journal-title":"Cancer Cell"},{"key":"B99","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-020-3017-y","article-title":"Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture","volume":"589","author":"Yusufova","year":"2021","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1514","article-title":"SETD2 haploinsufficiency enhances germinal center-associated AICDA somatic hypermutation to drive B-cell lymphomagenesis","volume":"12","author":"Leung","year":"2022","journal-title":"Cancer Discov"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1110","article-title":"Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation","volume":"69","author":"Cattoretti","year":"2009","journal-title":"Cancer Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2047","article-title":"The sphingosine 1-phosphate receptor S1P2 maintains the homeostasis of germinal center B cells and promotes niche confinement","volume":"12","author":"Green","year":"2011","journal-title":"Nat Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/nature13765","article-title":"Loss of signalling via G\u03b113 in germinal centre B-cell-derived lymphoma","volume":"516","author":"Muppidi","year":"2014","journal-title":"Nature"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1003-z","article-title":"S-Geranylgeranyl-L-glutathione is a ligand for human B cell-confinement receptor P2RY8","volume":"567","author":"Lu","year":"2019","journal-title":"Nature"},{"key":"B105","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.cell.2016.08.032","article-title":"Loss of the HVEM tumor suppressor in lymphoma and restoration by modified CAR-T cells","volume":"167","author":"Boice","year":"2016","journal-title":"Cell"},{"key":"B106","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.immuni.2019.05.022","article-title":"The HVEM-BTLA axis restrains T cell help to germinal center B cells and functions as a cell-extrinsic suppressor in lymphomagenesis","volume":"51","author":"Mintz","year":"2019","journal-title":"Immunity"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107522","article-title":"Cathepsin S alterations induce a tumor-promoting immune microenvironment in follicular lymphoma","volume":"31","author":"Bararia","year":"2020","journal-title":"Cell Rep"},{"key":"B108","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ccell.2020.03.016","article-title":"Cathepsin S regulates antigen processing and T cell activity in non-Hodgkin lymphoma","volume":"37","author":"Dheilly","year":"2020","journal-title":"Cancer Cell"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3473","article-title":"Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma","volume":"48","author":"Okosun","year":"2016","journal-title":"Nat Genet"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-019-0098-8","article-title":"Oncogenic Rag GTPase signaling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR","volume":"1","author":"Ortega-Molina","year":"2019","journal-title":"Nat Metab"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9969","article-title":"Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma","volume":"9","author":"Oricchio","year":"2017","journal-title":"Sci Transl Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.09.035","article-title":"The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma","volume":"147","author":"Oricchio","year":"2011","journal-title":"Cell"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20132120","article-title":"Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy","volume":"211","author":"Oricchio","year":"2014","journal-title":"J Exp Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-04-640912","article-title":"DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma","volume":"126","author":"Amin","year":"2015","journal-title":"Blood"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-04-640805","article-title":"Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells","volume":"126","author":"Linley","year":"2015","journal-title":"Blood"},{"key":"B116","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","article-title":"How the ageing microenvironment influences tumour progression","volume":"20","author":"Fane","year":"2020","journal-title":"Nat Rev Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1288110\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T16:59:09Z","timestamp":1698944349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1288110\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":116,"alternative-id":["10.3389\/fimmu.2023.1288110"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1288110","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"article-number":"1288110"}}